GENEVA, Aug. 21 -- MODERNATX, INC. filed a patent application (US2026/014883) for “INDIVIDUALIZED NEOANTIGEN VACCINES FOR THE TREATMENT OF BLADDER CANCER”. With publication no. WO/2026/173963, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 39/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....